An animal model is a nonhuman species that can replicate the characteristics of a biological process, or a disease in humans. Biomedical research uses animal models. To target specific diseases in humans, genetic engineering is used to create different types of mice models. Biomedical research often uses mice model technology because they share many of the same characteristics as humans.
Increased investment in Biomedical Research Drives Demand for Mice Model Technology



The most important indicator of a country’s research landscape is its investment in biomedical research. Biomedical research spending has increased dramatically over the past decade in developed countries like the U.S., UK, and other nations. The majority of these investments go towards R&D for animal models.
The National Institutes of Health (NIH), which is the largest advocate for biomedical research, had a budget of approximately US$ 31 Bn in 2019. It was followed by the Bill & Melinda Gates Foundation and the Wellcome Trust (each with about US$ 1.08 Bn; 3.1%). Around 89.6%, or approximately US$ 32 Bn, of all grants for biomedical research, were awarded to recipient organizations in the U.S. The global market for mice-related technologies is expected to grow due to an increase in biomedical research funding.
To get a first-hand overview of the report, Request a Sample
Global Mice Model Technologies Market: Key Developments



July 2022 GemPharmatech announced it had signed a strategic licensing agreement with Charles River Laboratories, Inc. to distribute its next-generation NODCRISPR Prkdc Il2r Gamma (NCG mouse lines) in North America.
March 2022 Charles River Laboratories entered into an agreement to sell, distribute, market and breed the SRG rat from Hera BioLabs to the international preclinical research community. The SRG, (Sprague Dawley Rag2, Il2rg – “SRG”), is an immunodeficient rodent model that was created by knockout mutations in Rag2 and Il2r gamma genes. This results in mature T, B, and NK cells. The combination of severe immunodeficiency and a larger organism makes the SRG Rat an excellent alternative to mice for certain preclinical research applications.
Table: Years considered for the study:



Details 
Report Attribute


2016-2020 
Historical Years


2021 
Base Year


2022 
Estimated Year


2028
Short Term Projection Year


2023
Projected Year


2032 
Long Term Projected Year



Market segment by Type, covers



CRISPR Knockout

CRISPR Knockin

Random Insertions

ES Cell Modification (Homologous Recombination)

Others
Market segment by Application can be divided into



Pharmaceutical Companies

Biotechnology Companies

Academic and Research Facilities

Contract Research and Manufacturing Organizations
Market segment by players, this report covers



BIOCYTOGEN

Charles River Laboratories

Cyagen Biosciences

Gempharmatech

genOway

ingenious targeting laboratory

Merck KGaA

Ozgene Pty Ltd.

Taconic Biosciences, Inc.

PolyGene AG

THE JACKSON LABORATORY

Yale School of Medicine

University of North Carolina

University of Nebraska Medical Center

Monash University

UMass Chan Medical School

University of Bonn

Columbia University

The University of Arizona
Regional Segment Analysis
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
Asia-Pacific (China, Japan, India, Rest of APAC)
South America (Brazil and the Rest of South America)
The Middle East and Africa (UAE, South Africa, Rest of MEA)
Frequently Asked Questions



How big was the global mice model technologies market in 2022?
How big will be the global mice model technologies market in 2031?
What was the CAGR of the global mice model technologies market from 2016-2021?
What will be the CAGR of the global mice model technologies market during the forecast period (2022–2031)?
Which are the prominent trends that affect the market growth?
What was the market share of the leading segment of the global mice model technologies market?
Which region will account for the major share of the global market during the forecast period?
Who are the prominent players in the global mice model technologies market?